alpha-amyrenone has been researched along with 11-keto-boswellic acid in 1 studies
Studies (alpha-amyrenone) | Trials (alpha-amyrenone) | Recent Studies (post-2010) (alpha-amyrenone) | Studies (11-keto-boswellic acid) | Trials (11-keto-boswellic acid) | Recent Studies (post-2010) (11-keto-boswellic acid) |
---|---|---|---|---|---|
8 | 0 | 4 | 16 | 0 | 10 |
Protein | Taxonomy | alpha-amyrenone (IC50) | 11-keto-boswellic acid (IC50) |
---|---|---|---|
Prostaglandin E synthase | Homo sapiens (human) | 6.5 | |
Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 3 | |
Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) | 9.45 | |
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 8.04 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukushima, EO; Muranaka, T; Nomura, Y; Vo, NNQ | 1 |
1 other study(ies) available for alpha-amyrenone and 11-keto-boswellic acid
Article | Year |
---|---|
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
Topics: Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Humans; Lipoxygenase Inhibitors; Pentacyclic Triterpenes; Structure-Activity Relationship | 2019 |